| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |